Macular Degeneration and Other Retinal Diseases and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Macular Degeneration (AMD) and Other Retinal Diseases Overall Market Size
2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size: 2022 VS 2032
2.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Macular Degeneration (AMD) and Other Retinal Diseases Players in Global Market
3.2 Top Global Macular Degeneration (AMD) and Other Retinal Diseases Companies Ranked by Revenue
3.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Companies
3.4 Top 3 and Top 5 Macular Degeneration (AMD) and Other Retinal Diseases Companies in Global Market, by Revenue in 2022
3.5 Global Companies Macular Degeneration (AMD) and Other Retinal Diseases Product Type
3.6 Tier 1, Tier 2 and Tier 3 Macular Degeneration (AMD) and Other Retinal Diseases Players in Global Market
3.6.1 List of Global Tier 1 Macular Degeneration (AMD) and Other Retinal Diseases Companies
3.6.2 List of Global Tier 2 and Tier 3 Macular Degeneration (AMD) and Other Retinal Diseases Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Markets, 2022 & 2032
4.1.2 Macular Degeneration
4.1.3 Diabetic Macular Edema
4.1.4 Diabetic Retinopathy(DR)
4.1.5 Retinal Vein Occlusion
4.1.6 Wet Age-Related Macular Degeneration (wAMD)
4.1.7 Dry Age-Related Macular Degeneration (dAMD)
4.1.8 Other
4.2 By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue & Forecasts
4.2.1 By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2023
4.2.2 By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2024-2032
4.2.3 By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue & Forecasts
5.2.1 By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2023
5.2.2 By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2024-2032
5.2.3 By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2022 & 2032
6.2 By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue & Forecasts
6.2.1 By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2023
6.2.2 By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2024-2032
6.2.3 By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032
6.3.2 US Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.3.3 Canada Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.3.4 Mexico Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032
6.4.2 Germany Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.3 France Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.4 U.K. Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.5 Italy Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.6 Russia Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.7 Nordic Countries Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.4.8 Benelux Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032
6.5.2 China Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.5.3 Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.5.4 South Korea Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.5.5 Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.5.6 India Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032
6.6.2 Brazil Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.6.3 Argentina Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032
6.7.2 Turkey Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.7.3 Israel Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.7.4 Saudi Arabia Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
6.7.5 UAE Macular Degeneration (AMD) and Other Retinal Diseases Market Size, 2018-2032
7 Macular Degeneration (AMD) and Other Retinal Diseases Companies Profiles
7.1 Regeneron Pharmaceuticals
7.1.1 Regeneron Pharmaceuticals Company Summary
7.1.2 Regeneron Pharmaceuticals Business Overview
7.1.3 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.1.4 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.1.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Company Summary
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.2.4 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.2.5 Bayer HealthCare Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.3.4 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.4.4 Roche Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Kanghong Pharma
7.5.1 Kanghong Pharma Company Summary
7.5.2 Kanghong Pharma Business Overview
7.5.3 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.5.4 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.5.5 Kanghong Pharma Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.6.4 Merck Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Company Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.7.4 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.7.5 Allergan Key News & Latest Developments
7.8 Santen Pharmaceutical
7.8.1 Santen Pharmaceutical Company Summary
7.8.2 Santen Pharmaceutical Business Overview
7.8.3 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.8.4 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.8.5 Santen Pharmaceutical Key News & Latest Developments
7.9 GlaxoSmithKline Pharmaceuticals
7.9.1 GlaxoSmithKline Pharmaceuticals Company Summary
7.9.2 GlaxoSmithKline Pharmaceuticals Business Overview
7.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.9.4 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Pharmaceuticals Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.10.4 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Acucela
7.11.1 Acucela Company Summary
7.11.2 Acucela Business Overview
7.11.3 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.11.4 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.11.5 Acucela Key News & Latest Developments
7.12 Valent Pharmaceuticals
7.12.1 Valent Pharmaceuticals Company Summary
7.12.2 Valent Pharmaceuticals Business Overview
7.12.3 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.12.4 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.12.5 Valent Pharmaceuticals Key News & Latest Developments
7.13 IVERIC
7.13.1 IVERIC Company Summary
7.13.2 IVERIC Business Overview
7.13.3 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Major Product Offerings
7.13.4 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global Market (2018-2023)
7.13.5 IVERIC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Macular Degeneration (AMD) and Other Retinal Diseases Market Opportunities & Trends in Global Market
Table 2. Macular Degeneration (AMD) and Other Retinal Diseases Market Drivers in Global Market
Table 3. Macular Degeneration (AMD) and Other Retinal Diseases Market Restraints in Global Market
Table 4. Key Players of Macular Degeneration (AMD) and Other Retinal Diseases in Global Market
Table 5. Top Macular Degeneration (AMD) and Other Retinal Diseases Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Share by Companies, 2018-2023
Table 8. Global Companies Macular Degeneration (AMD) and Other Retinal Diseases Product Type
Table 9. List of Global Tier 1 Macular Degeneration (AMD) and Other Retinal Diseases Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Macular Degeneration (AMD) and Other Retinal Diseases Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Macular Degeneration (AMD) and Other Retinal Diseases Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2024-2032
Table 30. Regeneron Pharmaceuticals Company Summary
Table 31. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 32. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 33. Regeneron Pharmaceuticals Key News & Latest Developments
Table 34. Bayer HealthCare Company Summary
Table 35. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 36. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer HealthCare Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 40. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 44. Roche Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Kanghong Pharma Company Summary
Table 47. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 48. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 49. Kanghong Pharma Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 52. Merck Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Allergan Company Summary
Table 55. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 56. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 57. Allergan Key News & Latest Developments
Table 58. Santen Pharmaceutical Company Summary
Table 59. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 60. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 61. Santen Pharmaceutical Key News & Latest Developments
Table 62. GlaxoSmithKline Pharmaceuticals Company Summary
Table 63. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 64. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Pharmaceuticals Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 68. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Acucela Company Summary
Table 71. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 72. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 73. Acucela Key News & Latest Developments
Table 74. Valent Pharmaceuticals Company Summary
Table 75. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 76. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 77. Valent Pharmaceuticals Key News & Latest Developments
Table 78. IVERIC Company Summary
Table 79. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Offerings
Table 80. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Revenue (US$, Mn) & (2018-2023)
Table 81. IVERIC Key News & Latest Developments
List of Figures
Figure 1. Macular Degeneration (AMD) and Other Retinal Diseases Segment by Type in 2022
Figure 2. Macular Degeneration (AMD) and Other Retinal Diseases Segment by Application in 2022
Figure 3. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Macular Degeneration (AMD) and Other Retinal Diseases Revenue in 2022
Figure 8. By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 9. By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 10. By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 12. By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 14. By Region - Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 15. By Country - North America Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 16. US Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 20. Germany Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 21. France Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 28. China Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 32. India Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 34. Brazil Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share, 2018-2032
Figure 37. Turkey Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Macular Degeneration (AMD) and Other Retinal Diseases Revenue, (US$, Mn), 2018-2032
Figure 41. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
